PBT 2.44% 4.0¢ prana biotechnology limited

Prana Biotechnology Limited (ADR) Receives Average Target Price of $3

  1. 1,847 Posts.
    lightbulb Created with Sketch. 1
    Mathew Donald · Feb 4th, 2015 · 0 Comment

    Prana Biotechnology Limited (ADR) (NASDAQRAN) shares are expected to touch $3 in the short term. This short term price target has been shared by 1 analysts. However, the standard deviation of short term price estimate has been valued at 0. The target price could hit $3 on the higher end and $3 on the lower end.The information is based on average recommendation on company rating and price target for short term (6 to 12 months) .

    Prana Biotechnology Limited (ADR) (NASDAQRAN) : Strong bullish mood helped the shares of Prana Biotechnology Limited (ADR) (NASDAQRAN) appreciate in value. The share price gained 0.14 points or 9.33% to close at $1.64 with 391,313 shares exchanging hands. The trading began on a bullish sentiment but no considerable downsides were seen throughout the day; the intraday low was registered at $1.51. However, the shares hit an intraday high of $1.65. The previous close of the share price was $1.5. Prana Biotechnology Limited (ADR) (NASDAQRAN) has a market cap of $80 million and the number of outstanding shares is calculated to be 48,894,000. The 52-week low of the share price is $1.36.

    Prana Biotechnology Limited (ADR) (NASDAQRAN) has a short ratio of 10.62 , which means that the counter should take 10.62 days to cover the total short interest. A high short ratio indicates a high build-up of short positions in the counter whereas a low short ratio implies that there are fewer short positions. The average daily volume for the last 20 days is 190,730 shares. The volume traded during the last 20 days is 0.39% of the total outstanding shares. The 1-month %change in short interest is -9.05%.The shares have witnessed a change of -20.4% in short interest in the past 3 months. The total monthly shares shorted are 0.047 times the total common shares outstanding.
    Prana Biotechnology Limited (Prana) is development stage company. The Company is engaged in develop therapeutic drugs designed to treat the underlying causes of degeneration of the brain and the eye as the aging process progresses, initially focusing on Alzheimers disease. During the fiscal year ended June 30, 2012 (fiscal 2012), the Company is also focusing on Huntingtons and Parkinsons diseases. Other potential applications for its therapies include certain cancers, age-related macular degeneration, Motor Neuron disease, Creutzfeldt-Jakob disease and age-related cataracts.
watchlist Created with Sketch. Add PBT (ASX) to my watchlist
(20min delay)
Mkt cap ! $22.18M
Open High Low Value Volume
3.9¢ 4.0¢ 3.9¢ $1.317K 33.11K

Buyers (Bids)

No. Vol. Price($)
1 212026 4.0¢

Sellers (Offers)

Price($) Vol. No.
4.2¢ 200000 1
View Market Depth
Last update - 11.55am 15/02/2019 (20 minute delay) ?
PBT (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.